CG Oncology, Inc. CGON

Set alert

64.80 USD -2.91 (-4.30%)

At closeNov 5, 2026, 4:52 PM EST

64.80 0.00 0.00%

After hours · Nov 5, 4:52 PM ET

64.16 Day range 67.34

35.80 52-week range 80.97

Held by insiders 0.23%

Held by institutions 113.16%

Float held by institutions 113.42%

Institutions 343

Top institutional holders
Holder	% held	Shares	Value	Reported
RTW Investments LP	9.61%	8,514,590	551.75M	Jun 29, 2026
T. Rowe Price Investment Management, Inc.	7.46%	6,616,899	428.78M	Jun 29, 2026
Decheng Capital LLC	7.19%	6,371,669	412.88M	Jun 29, 2026
Blackrock Inc.	7.06%	6,256,288	405.41M	Jun 29, 2026
Wellington Management Group, LLP	6.01%	5,324,751	345.04M	Jun 29, 2026
FMR, LLC	4.69%	4,161,493	269.66M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund	3.23%	2,860,428	185.36M	Jul 30, 2026
T. ROWE PRICE CAPITAL APPRECIATION Fd., INC.-T. Rowe Price Capital App	2.90%	2,574,868	166.85M	Jun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	2.69%	2,383,134	154.43M	Jun 29, 2026
iShares Trust-iShares Russell 2000 ETF	2.16%	1,911,075	123.84M	Sep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund	1.94%	1,720,068	111.46M	Jun 29, 2026
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF	1.74%	1,541,674	99.90M	Sep 29, 2026

CGON insiders
Insider	Relation	Latest transaction	Date	Shares held
KUAN ARTHUR	Chief Executive Officer	Conversion of Exercise of derivative security	Mar 11, 2026	198,916
LIU BRIAN GUAN-CHYUN M.D.	Director	Purchase	Jun 24, 2026	0
MULAY JAMES J.	Director	Conversion of Exercise of derivative security	Jul 9, 2026	0
POST LEONARD E	Director	Conversion of Exercise of derivative security	Oct 14, 2026	0
SONG HONG FANG	Director	Sale	Sep 2, 2025	0

Held by funds